{"entity":{"type":"insider","cik":"0001279105","url":"/insider/0001279105","json_url":"/insider/0001279105.json","name":"ELAN PHARMACEUTICAL INVESTMENTS LTD","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":60,"n_filings":17,"first":"2004-02-10","last":"2004-07-02","span_basis":"filed_date"},"name_variants":[{"name":"ELAN PHARMACEUTICAL INVESTMENTS LTD","source":"filing","n_filings":17,"first_seen":"2004-02-10","last_seen":"2004-07-02"}],"transactions":[{"id":305794,"accession":"0000950162-04-000810","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000950162-04-000810","line_url":"/filing/0000950162-04-000810","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"DOV PHARMACEUTICAL INC","issuer_ticker":"DOVP","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN PHARMACEUTICAL INVESTMENTS LTD; ELAN INTERNATIONAL SERVICES LTD; ELAN CORP PLC","owner_display_name":"ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":174500.0,"shares_display":"174,500","price_per_share":13.902120343839542,"price_display":"13.90","price_state":"stated","total_value":2425920.0,"total_display":"2,425,920.00","total_whole":"2,425,920","shares_owned_after":2720162.0,"shares_owned_after_display":"2,720,162","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-07-01","filed_date":"2004-07-02","scope":"insider","n_lines":3},{"id":305791,"accession":"0000950162-04-000810","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950162-04-000810","line_url":"/filing/0000950162-04-000810","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"DOV PHARMACEUTICAL INC","issuer_ticker":"DOVP","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN PHARMACEUTICAL INVESTMENTS LTD; ELAN INTERNATIONAL SERVICES LTD; ELAN CORP PLC","owner_display_name":"ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":149199.0,"shares_display":"149,199","price_per_share":14.034751908524855,"price_display":"14.03","price_state":"stated","total_value":2093970.95,"total_display":"2,093,970.95","total_whole":"2,093,971","shares_owned_after":2907162.0,"shares_owned_after_display":"2,907,162","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-06-30","filed_date":"2004-07-02","scope":"insider","n_lines":4},{"id":568019,"accession":"0000950162-04-000744","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950162-04-000744","line_url":"/filing/0000950162-04-000744#line-1","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"BIOJECT MEDICAL TECHNOLOGIES INC","issuer_ticker":"BJCT","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN PHARMACEUTICAL INVESTMENTS LTD; ELAN INTERNATIONAL SERVICES LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2036148.0,"shares_display":"2,036,148","price_per_share":1.96,"price_display":"1.96","price_state":"stated","total_value":3990850.08,"total_display":"3,990,850.08","total_whole":"3,990,850","shares_owned_after":347788.0,"shares_owned_after_display":"347,788","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-06-15","filed_date":"2004-06-17","scope":"insider"},{"id":384197,"accession":"0000950162-04-000547","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000950162-04-000547","line_url":"/filing/0000950162-04-000547","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"DOV PHARMACEUTICAL INC","issuer_ticker":"DOVP","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN PHARMACEUTICAL INVESTMENTS LTD; ELAN INTERNATIONAL SERVICES LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":574521.0,"shares_display":"574,521","price_per_share":19.222682164794673,"price_display":"19.22","price_state":"stated","total_value":11043834.58,"total_display":"11,043,834.58","total_whole":"11,043,835","shares_owned_after":136699.0,"shares_owned_after_display":"136,699","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-27","filed_date":"2004-04-28","scope":"insider","n_lines":9},{"id":490229,"accession":"0000950162-04-000529","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000950162-04-000529","line_url":"/filing/0000950162-04-000529#line-5","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"BIOJECT MEDICAL TECHNOLOGIES INC","issuer_ticker":"BJCT","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN INTERNATIONAL SERVICES LTD; ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","total_whole":"15,000","shares_owned_after":2383936.0,"shares_owned_after_display":"2,383,936","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-20","filed_date":"2004-04-21","scope":"insider"},{"id":490228,"accession":"0000950162-04-000529","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950162-04-000529","line_url":"/filing/0000950162-04-000529","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"BIOJECT MEDICAL TECHNOLOGIES INC","issuer_ticker":"BJCT","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN INTERNATIONAL SERVICES LTD; ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41000.0,"shares_display":"41,000","price_per_share":3.0033170731707317,"price_display":"3.00","price_state":"stated","total_value":123136.0,"total_display":"123,136.00","total_whole":"123,136","shares_owned_after":2388936.0,"shares_owned_after_display":"2,388,936","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-19","filed_date":"2004-04-21","scope":"insider","n_lines":4},{"id":219531,"accession":"0000950162-04-000520","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950162-04-000520","line_url":"/filing/0000950162-04-000520#line-2","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"BIOJECT MEDICAL TECHNOLOGIES INC","issuer_ticker":"BJCT","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN PHARMACEUTICAL INVESTMENTS LTD; ELAN INTERNATIONAL SERVICES LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","total_whole":"15,000","shares_owned_after":2429936.0,"shares_owned_after_display":"2,429,936","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-16","filed_date":"2004-04-19","scope":"insider"},{"id":219530,"accession":"0000950162-04-000520","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950162-04-000520","line_url":"/filing/0000950162-04-000520#line-1","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"BIOJECT MEDICAL TECHNOLOGIES INC","issuer_ticker":"BJCT","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN PHARMACEUTICAL INVESTMENTS LTD; ELAN INTERNATIONAL SERVICES LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":3.07,"price_display":"3.07","price_state":"stated","total_value":15350.0,"total_display":"15,350.00","total_whole":"15,350","shares_owned_after":2434936.0,"shares_owned_after_display":"2,434,936","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-15","filed_date":"2004-04-19","scope":"insider"},{"id":562904,"accession":"0000950162-04-000498","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950162-04-000498","line_url":"/filing/0000950162-04-000498#line-1","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"BIOJECT MEDICAL TECHNOLOGIES INC","issuer_ticker":"BJCT","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN PHARMACEUTICAL INVESTMENTS LTD; ELAN CORP PLC; ELAN INTERNATIONAL SERVICES LTD","owner_display_name":"ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":7500.0,"total_display":"7,500.00","total_whole":"7,500","shares_owned_after":2439936.0,"shares_owned_after_display":"2,439,936","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-13","filed_date":"2004-04-15","scope":"insider"},{"id":350811,"accession":"0000950162-04-000479","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950162-04-000479","line_url":"/filing/0000950162-04-000479#line-1","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"BIOJECT MEDICAL TECHNOLOGIES INC","issuer_ticker":"BJCT","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN INTERNATIONAL SERVICES LTD; ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7500.0,"shares_display":"7,500","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":22500.0,"total_display":"22,500.00","total_whole":"22,500","shares_owned_after":2442436.0,"shares_owned_after_display":"2,442,436","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-07","filed_date":"2004-04-09","scope":"insider"},{"id":582640,"accession":"0000950162-04-000476","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950162-04-000476","line_url":"/filing/0000950162-04-000476#line-2","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"BIOJECT MEDICAL TECHNOLOGIES INC","issuer_ticker":"BJCT","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN INTERNATIONAL SERVICES LTD; ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":90000.0,"total_display":"90,000.00","total_whole":"90,000","shares_owned_after":2449936.0,"shares_owned_after_display":"2,449,936","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-06","filed_date":"2004-04-07","scope":"insider"},{"id":582639,"accession":"0000950162-04-000476","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950162-04-000476","line_url":"/filing/0000950162-04-000476#line-1","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"BIOJECT MEDICAL TECHNOLOGIES INC","issuer_ticker":"BJCT","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN INTERNATIONAL SERVICES LTD; ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65000.0,"shares_display":"65,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":195000.0,"total_display":"195,000.00","total_whole":"195,000","shares_owned_after":2479936.0,"shares_owned_after_display":"2,479,936","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-05","filed_date":"2004-04-07","scope":"insider"},{"id":305787,"accession":"0000950162-04-000461","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950162-04-000461","line_url":"/filing/0000950162-04-000461#line-2","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"BIOJECT MEDICAL TECHNOLOGIES INC","issuer_ticker":"BJCT","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN PHARMACEUTICAL INVESTMENTS LTD; ELAN INTERNATIONAL SERVICES LTD; ELAN CORP PLC","owner_display_name":"ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","total_whole":"15,000","shares_owned_after":2544936.0,"shares_owned_after_display":"2,544,936","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-02","filed_date":"2004-04-05","scope":"insider"},{"id":305786,"accession":"0000950162-04-000461","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950162-04-000461","line_url":"/filing/0000950162-04-000461#line-1","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"BIOJECT MEDICAL TECHNOLOGIES INC","issuer_ticker":"BJCT","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN PHARMACEUTICAL INVESTMENTS LTD; ELAN INTERNATIONAL SERVICES LTD; ELAN CORP PLC","owner_display_name":"ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16000.0,"shares_display":"16,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":48000.0,"total_display":"48,000.00","total_whole":"48,000","shares_owned_after":2549936.0,"shares_owned_after_display":"2,549,936","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-04-01","filed_date":"2004-04-05","scope":"insider"},{"id":373055,"accession":"0000950162-04-000409","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950162-04-000409","line_url":"/filing/0000950162-04-000409#line-2","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"BIOJECT MEDICAL TECHNOLOGIES INC","issuer_ticker":"BJCT","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN PHARMACEUTICAL INVESTMENTS LTD; ELAN INTERNATIONAL SERVICES LTD; ELAN CORP PLC","owner_display_name":"ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23200.0,"shares_display":"23,200","price_per_share":3.21,"price_display":"3.21","price_state":"stated","total_value":74472.0,"total_display":"74,472.00","total_whole":"74,472","shares_owned_after":2565936.0,"shares_owned_after_display":"2,565,936","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-03-25","filed_date":"2004-03-26","scope":"insider"},{"id":373054,"accession":"0000950162-04-000409","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950162-04-000409","line_url":"/filing/0000950162-04-000409#line-1","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"BIOJECT MEDICAL TECHNOLOGIES INC","issuer_ticker":"BJCT","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN PHARMACEUTICAL INVESTMENTS LTD; ELAN INTERNATIONAL SERVICES LTD; ELAN CORP PLC","owner_display_name":"ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":3.19,"price_display":"3.19","price_state":"stated","total_value":79750.0,"total_display":"79,750.00","total_whole":"79,750","shares_owned_after":2589136.0,"shares_owned_after_display":"2,589,136","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-03-24","filed_date":"2004-03-26","scope":"insider"},{"id":327229,"accession":"0000950162-04-000366","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950162-04-000366","line_url":"/filing/0000950162-04-000366#line-1","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"BIOJECT MEDICAL TECHNOLOGIES INC","issuer_ticker":"BJCT","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN PHARMACEUTICAL INVESTMENTS LTD; ELAN CORP PLC; ELAN INTERNATIONAL SERVICES LTD","owner_display_name":"ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":3.1743,"price_display":"3.17","price_state":"stated","total_value":111100.5,"total_display":"111,100.50","total_whole":"111,101","shares_owned_after":2614136.0,"shares_owned_after_display":"2,614,136","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-03-16","filed_date":"2004-03-18","scope":"insider"},{"id":425147,"accession":"0000950162-04-000356","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950162-04-000356","line_url":"/filing/0000950162-04-000356#line-1","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"BIOJECT MEDICAL TECHNOLOGIES INC","issuer_ticker":"BJCT","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN PHARMACEUTICAL INVESTMENTS LTD; ELAN INTERNATIONAL SERVICES LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":3.18,"price_display":"3.18","price_state":"stated","total_value":79500.0,"total_display":"79,500.00","total_whole":"79,500","shares_owned_after":2649136.0,"shares_owned_after_display":"2,649,136","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-03-12","filed_date":"2004-03-16","scope":"insider"},{"id":234601,"accession":"0000950162-04-000345","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950162-04-000345","line_url":"/filing/0000950162-04-000345#line-1","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"BIOJECT MEDICAL TECHNOLOGIES INC","issuer_ticker":"BJCT","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN INTERNATIONAL SERVICES LTD; ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":3.16,"price_display":"3.16","price_state":"stated","total_value":47400.0,"total_display":"47,400.00","total_whole":"47,400","shares_owned_after":2674136.0,"shares_owned_after_display":"2,674,136","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-03-09","filed_date":"2004-03-11","scope":"insider"},{"id":211055,"accession":"0000950162-04-000261","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950162-04-000261","line_url":"/filing/0000950162-04-000261#line-1","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"DOV PHARMACEUTICAL INC","issuer_ticker":"DOVP","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN INTERNATIONAL SERVICES LTD; ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":146025.0,"shares_display":"146,025","price_per_share":12.84,"price_display":"12.84","price_state":"stated","total_value":1874961.0,"total_display":"1,874,961.00","total_whole":"1,874,961","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-02-23","filed_date":"2004-02-25","scope":"insider"},{"id":585694,"accession":"0000950162-04-000235","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000950162-04-000235","line_url":"/filing/0000950162-04-000235","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"DOR BIOPHARMA INC","issuer_ticker":"DOR","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN INTERNATIONAL SERVICES LTD; ELAN PHARMACEUTICAL INVESTMENTS LTD; ELAN CORP PLC","owner_display_name":"ELAN INTERNATIONAL SERVICES LTD","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1306300.0,"shares_display":"1,306,300","price_per_share":1.0170443236622522,"price_display":"1.02","price_state":"stated","total_value":1328565.0,"total_display":"1,328,565.00","total_whole":"1,328,565","shares_owned_after":162600.0,"shares_owned_after_display":"162,600","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-02-13","filed_date":"2004-02-18","scope":"insider","n_lines":7},{"id":205097,"accession":"0000950162-04-000182","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0000950162-04-000182","line_url":"/filing/0000950162-04-000182#line-16","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"DOV PHARMACEUTICAL INC","issuer_ticker":"DOVP","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN INTERNATIONAL SERVICES LTD; ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":360600.0,"shares_display":"360,600","price_per_share":12.84,"price_display":"12.84","price_state":"stated","total_value":4630104.0,"total_display":"4,630,104.00","total_whole":"4,630,104","shares_owned_after":146025.0,"shares_owned_after_display":"146,025","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-02-11","filed_date":"2004-02-13","scope":"insider"},{"id":205096,"accession":"0000950162-04-000182","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0000950162-04-000182","line_url":"/filing/0000950162-04-000182#line-15","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"DOV PHARMACEUTICAL INC","issuer_ticker":"DOVP","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN INTERNATIONAL SERVICES LTD; ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":13.14,"price_display":"13.14","price_state":"stated","total_value":63072.0,"total_display":"63,072.00","total_whole":"63,072","shares_owned_after":516325.0,"shares_owned_after_display":"516,325","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-02-11","filed_date":"2004-02-13","scope":"insider"},{"id":205095,"accession":"0000950162-04-000182","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0000950162-04-000182","line_url":"/filing/0000950162-04-000182#line-14","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"DOV PHARMACEUTICAL INC","issuer_ticker":"DOVP","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN INTERNATIONAL SERVICES LTD; ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":13.01,"price_display":"13.01","price_state":"stated","total_value":62448.0,"total_display":"62,448.00","total_whole":"62,448","shares_owned_after":506625.0,"shares_owned_after_display":"506,625","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-02-11","filed_date":"2004-02-13","scope":"insider"},{"id":205094,"accession":"0000950162-04-000182","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0000950162-04-000182","line_url":"/filing/0000950162-04-000182#line-13","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"DOV PHARMACEUTICAL INC","issuer_ticker":"DOVP","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN INTERNATIONAL SERVICES LTD; ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2300.0,"shares_display":"2,300","price_per_share":13.15,"price_display":"13.15","price_state":"stated","total_value":30245.0,"total_display":"30,245.00","total_whole":"30,245","shares_owned_after":521125.0,"shares_owned_after_display":"521,125","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-02-11","filed_date":"2004-02-13","scope":"insider"},{"id":205093,"accession":"0000950162-04-000182","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0000950162-04-000182","line_url":"/filing/0000950162-04-000182#line-12","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"DOV PHARMACEUTICAL INC","issuer_ticker":"DOVP","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN INTERNATIONAL SERVICES LTD; ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1700.0,"shares_display":"1,700","price_per_share":13.03,"price_display":"13.03","price_state":"stated","total_value":22151.0,"total_display":"22,151.00","total_whole":"22,151","shares_owned_after":512825.0,"shares_owned_after_display":"512,825","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-02-11","filed_date":"2004-02-13","scope":"insider"},{"id":205092,"accession":"0000950162-04-000182","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0000950162-04-000182","line_url":"/filing/0000950162-04-000182#line-11","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"DOV PHARMACEUTICAL INC","issuer_ticker":"DOVP","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN INTERNATIONAL SERVICES LTD; ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1300.0,"shares_display":"1,300","price_per_share":13.011,"price_display":"13.01","price_state":"stated","total_value":16914.3,"total_display":"16,914.30","total_whole":"16,914","shares_owned_after":511425.0,"shares_owned_after_display":"511,425","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-02-11","filed_date":"2004-02-13","scope":"insider"},{"id":205091,"accession":"0000950162-04-000182","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0000950162-04-000182","line_url":"/filing/0000950162-04-000182#line-10","is_derivative":false,"issuer_cik":"0000737572","issuer_name":"DOV PHARMACEUTICAL INC","issuer_ticker":"DOVP","issuer_name_source":null,"issuer_url":"/issuer/0000737572","owner_cik":null,"owner_name":"ELAN CORP PLC; ELAN INTERNATIONAL SERVICES LTD; ELAN PHARMACEUTICAL INVESTMENTS LTD","owner_display_name":"ELAN CORP PLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":13.1,"price_display":"13.10","price_state":"stated","total_value":13100.0,"total_display":"13,100.00","total_whole":"13,100","shares_owned_after":515225.0,"shares_owned_after_display":"515,225","ownership_form":"I","is_10b5_1":null,"transaction_date":"2004-02-11","filed_date":"2004-02-13","scope":"insider"}],"collapsed":true,"next_cursor":"2004-02-11|205091","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001066833","name":"DOV PHARMACEUTICAL INC","url":"/issuer/0001066833","role":"Ten percent owner","n_filings":4,"first_seen":"2004-02-13","last_seen":"2004-07-02"},{"type":"issuer","type_label":"ISSUER","cik":"0000810084","name":"BIOJECT MEDICAL TECHNOLOGIES INC","url":"/issuer/0000810084","role":"Ten percent owner","n_filings":12,"first_seen":"2004-02-10","last_seen":"2004-06-17"},{"type":"issuer","type_label":"ISSUER","cik":"0000812796","name":"DOR BIOPHARMA INC","url":"/issuer/0000812796","role":"Ten percent owner","n_filings":1,"first_seen":"2004-02-18","last_seen":"2004-02-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001279105","retrieved_at":"2026-08-23T05:45:49+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}